Olivier Lantz

information fusion process from receptors radio, and radioelectric reception device

Philippe Ziegler, Olivier Lantz, 2005 .

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Olivier Lantz, Laurence Zitvogel, Clotilde Théry, 2015, Oncoimmunology.

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Olivier Lantz, Fabian Birzele, Roland Schmucki, 2015, International journal of cancer.

Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

Olivier Lantz, Pierre Affaticati, Seiamak Bahram, 2003, Nature.

Dendritic Cell Maturation Controls Adhesion, Synapse Formation, and the Duration of the Interactions with Naive T Lymphocytes

Olivier Lantz, Sebastian Amigorena, Federica Benvenuti, 2004, The Journal of Immunology.

High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.

Olivier Lantz, Anne Vincent-Salomon, Thierry Dorval, 2014, Cancer research.

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Olivier Lantz, Laurence Zitvogel, Sebastian Amigorena, 2005, Journal of Translational Medicine.

Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients

Olivier Lantz, Jérôme Couturier, P. Petrow, 2012, PloS one.

CD4 cells can be more efficient at tumor rejection than CD8 cells.

Olivier Lantz, Ainhoa Perez-Diez, Polly Matzinger, 2007 .